Wim A. Buurman focuses on Internal medicine, Endocrinology, Immunology, Tumor necrosis factor alpha and Inflammation. As part of his studies on Internal medicine, Wim A. Buurman frequently links adjacent subjects like Gastroenterology. His work in Endocrinology is not limited to one particular discipline; it also encompasses Acute-phase protein.
In his study, Pneumococcal pneumonia and Streptococcus pneumoniae is strongly linked to Pneumonia, which falls under the umbrella field of Immunology. Wim A. Buurman combines subjects such as Cytokine, Lipopolysaccharide, Shock, Pathology and Molecular biology with his study of Tumor necrosis factor alpha. His work deals with themes such as Calprotectin, Kidney and Intestinal permeability, which intersect with Inflammation.
Wim A. Buurman focuses on Internal medicine, Immunology, Endocrinology, Tumor necrosis factor alpha and Inflammation. The Internal medicine study combines topics in areas such as Gastroenterology, Cardiology, Surgery and Pathology. His Pathology research integrates issues from Reperfusion injury, Ischemia and Transplantation.
His research ties Pharmacology and Immunology together. His research integrates issues of Cytokine, Lipopolysaccharide, Receptor, Molecular biology and Necrosis in his study of Tumor necrosis factor alpha. His Inflammation study typically links adjacent topics like Apoptosis.
Wim A. Buurman mainly focuses on Internal medicine, Gastroenterology, Endocrinology, Inflammation and Pathology. Much of his study explores Internal medicine relationship to Immunology. His Immunology research incorporates elements of Inflammatory bowel disease and Calprotectin.
Wim A. Buurman has included themes like Duodenal-jejunal bypass liner, Type 2 diabetes, Cystic fibrosis, Urinary system and Disease in his Gastroenterology study. His studies in Inflammation integrate themes in fields like Tumor necrosis factor alpha, Interleukin, Wound healing and Pharmacology. Wim A. Buurman works mostly in the field of Pathology, limiting it down to concerns involving Acute mesenteric ischemia and, occasionally, Intestinal ischemia.
His scientific interests lie mostly in Internal medicine, Endocrinology, Gastroenterology, Inflammation and Pathology. His Internal medicine study combines topics from a wide range of disciplines, such as Surgery and Intestinal Fatty Acid-Binding Protein. His Endocrinology study integrates concerns from other disciplines, such as Splanchnic and Perfusion.
His Gastroenterology study combines topics in areas such as Incretin, Duodenal-jejunal bypass liner, Type 2 diabetes and Insulin. His Inflammation study deals with the bigger picture of Immunology. His work on Staining, Goblet cell, Necrosis and Mucin as part of general Pathology research is frequently linked to Mucus, bridging the gap between disciplines.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Intestinal permeability – a new target for disease prevention and therapy
Stephan C. Bischoff;Giovanni Barbara;Wim Buurman;Theo Ockhuizen.
BMC Gastroenterology (2014)
Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease.
A. M. W. J. Schols;W. A. Buurman;A. J. Staal-Van Den Brekel;M. A. Dentener.
Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation
Marc A.R.C. Daemen;Cornelis van ‘t Veer;Geertrui Denecker;Vincent H. Heemskerk.
Journal of Clinical Investigation (1999)
In Vivo Expression of Toll-Like Receptor 2 and 4 by Renal Epithelial Cells: IFN-γ and TNF-α Mediated Up-Regulation During Inflammation
Tim G. A. M. Wolfs;Wim A. Buurman;Annemarie van Schadewijk;Bart de Vries.
Journal of Immunology (2002)
Convergence and Amplification of Toll-Like Receptor (TLR) and Receptor for Advanced Glycation End Products (RAGE) Signaling Pathways via High Mobility Group B1 (HMGB1)
Judy R van Beijnum;Wim A Buurman;Arjan W Griffioen.
Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum.
Juanita H Vernooy;Mehmet Küçükaycan;Jan A Jacobs;Niels H Chavannes.
American Journal of Respiratory and Critical Care Medicine (2002)
Interleukin-6 Gene-Deficient Mice Show Impaired Defense against Pneumococcal Pneumonia
Tom van der Poll;Christopher V. Keogh;Xavier Guirao;Wim A. Buurman.
The Journal of Infectious Diseases (1997)
Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages.
M. A. Dentener;V. Bazil;E. J. U. Von Asmuth;M. Ceska.
Journal of Immunology (1993)
Impact of Blood Transfusions on Inflammatory Mediator Release in Patients Undergoing Cardiac Surgery
Erik Fransen;Jos Maessen;Mieke Dentener;Nicole Senden.
Plasma tumor necrosis factor and mortality in critically ill septic patients.
J. M. H. Debets;R. Kampmeijer;M. P. M. H. Van Der Linden;W. A. Buurman.
Critical Care Medicine (1989)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: